The investigator initiated Phase I trial of ADRCs (Cytori Cell Therapy™) in the patients with post radical prostatectomy erectile dysfunction
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 09 Jul 2018
Price : $35 *
At a glance
- Drugs ECCS 50 (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- 09 Jul 2018 Results presented in a Cytori Therapeutics Media Release.
- 09 Jul 2018 According to a Cytori Therapeutics Media Release, 12-month data from this study were published in the Journal of Urology.
- 18 May 2017 New trial record